Metformin and cancer mortality
The author analyses recent publications supporting the ability of metformin to decrease the risk of cancer morbidity and mortality in patients with type 2diabetes mellitus. Pre-history of the problem (including the use of biguanides for metabolic rehabilitation of oncological patients), the role of...
Saved in:
| Main Author: | Lev Mikhaylovich Bershteyn |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2010-09-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/5491 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gallic acid improves the metformin effects on diabetic kidney disease in mice
by: Yan Hong, et al.
Published: (2023-12-01) -
Risk of oncological diseases in patients with diabetes mellitus
by: Gagik Radikovich Galstyan
Published: (2009-12-01) -
Efficacy and safety of metformin-sitagliptin combination for the treatment of patients with diabetes mellitus and obesity
by: Alexander Sergeevich Ametov, et al.
Published: (2010-09-01) -
DIABETES MELLITUS TYPE 2 TREATMENT IN CHILDREN AND ADOLESCENTS: METFORMIN AS A FIRST AGENT OF CHOICE
by: T. L. Kuraeva
Published: (2012-01-01) -
A review of metformin and its place in the diabetes guidelines
by: Gail Mkele
Published: (2013-12-01)